[HTML][HTML] Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
S Eickelschulte, AL Riediger, AK Angeles, F Janke… - Cancers, 2022 - mdpi.com
Simple Summary Prostate cancer is a heterogeneous disease and a major cause of cancer
deaths worldwide. The most widely used prostate cancer biomarker, prostate-specific …
deaths worldwide. The most widely used prostate cancer biomarker, prostate-specific …
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
S Eickelschulte, AL Riediger, KA Arlou, F Janke… - …, 2022 - search.proquest.com
Current strategies for the clinical management of prostate cancer are inadequate for a
precise risk stratification between indolent and aggressive tumors. Recently developed …
precise risk stratification between indolent and aggressive tumors. Recently developed …
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer.
S Eickelschulte, AL Riediger, AK Angeles, F Janke… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: Prostate cancer is a heterogeneous disease and a major cause
of cancer deaths worldwide. The most widely used prostate cancer biomarker, prostate …
of cancer deaths worldwide. The most widely used prostate cancer biomarker, prostate …
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
S Eickelschulte, AL Riediger, AK Angeles… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Current strategies for the clinical management of prostate cancer are inadequate for a
precise risk stratification between indolent and aggressive tumors. Recently developed …
precise risk stratification between indolent and aggressive tumors. Recently developed …
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer.
S Eickelschulte, AL Riediger, AK Angeles, F Janke… - Cancers, 2022 - europepmc.org
Current strategies for the clinical management of prostate cancer are inadequate for a
precise risk stratification between indolent and aggressive tumors. Recently developed …
precise risk stratification between indolent and aggressive tumors. Recently developed …
[PDF][PDF] Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer. Cancers 2022, 14, 6094
S Eickelschulte, AL Riediger, AK Angeles, F Janke… - 2022 - pdfs.semanticscholar.org
Current strategies for the clinical management of prostate cancer are inadequate for a
precise risk stratification between indolent and aggressive tumors. Recently developed …
precise risk stratification between indolent and aggressive tumors. Recently developed …
[HTML][HTML] Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
S Eickelschulte, AL Riediger, AK Angeles, F Janke… - Cancers, 2022 - ncbi.nlm.nih.gov
Current strategies for the clinical management of prostate cancer are inadequate for a
precise risk stratification between indolent and aggressive tumors. Recently developed …
precise risk stratification between indolent and aggressive tumors. Recently developed …
[引用][C] Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer. Cancers 2022, 14, 6094
S Eickelschulte, AL Riediger, AK Angeles, F Janke… - 2022 - europepmc.org
Current strategies for the clinical management of prostate cancer are inadequate for a
precise risk stratification between indolent and aggressive tumors. Recently developed …
precise risk stratification between indolent and aggressive tumors. Recently developed …